About us

InnoBiotiQ was founded in 2022 as a spin-off from BIODESS – University of Costa Rica in cooperation with the University of Korea through the program HELICE UCR. We work with internationally recognized institutions to bring new products and services for established and emerging markets

Our Mission

We intend to be the driving business force in the region for improving functional and bioactive profiles of promising products, always including innovation in production, processing and the quality assurance that include bioactive molecules in their recipes, formulations and products.

Ph.D. Mirtha Navarro

Chief Operating Officer

With  commitment to excellence and the skills extend to establishing and fostering international networks, Ph.D. Navarro has engaged with stakeholders at prestigious institutions such as the United States Pharmacopeia, private sector entities, government bodies, and academia, with a focus in  dietary supplements.

Dr. Ing. Andrea Araya

Chief Executive Officer

Over a decade of analytical chemistry expertise in pharmaceutical, natural products and standards. Experience extends to quality control and regulatory compliance, bioactive isolation, purification and crystallization, with a keen understanding of ISO/IEC 17025, ISO/IEC guides 30-35, and ICH guides, ensuring adherence to the highest standards in the industry.

B. Biotec. Diego Alvarado

Chief Financial Officer

Results-driven scientist with experience in developing projects into startups through every phase, from initial prototyping to successful scaling and commercialization. With expertise spans a wide spectrum of technologies, bridging the intersection of chemistry, biotechnology and business strategy.